Zymeworks Inc. (ZYME) EVP Mark discloses stock and RSU holdings
Rhea-AI Filing Summary
Zymeworks Inc. executive Hollywood Mark, EVP & Chief Operating Officer, filed an initial ownership report showing his equity stake in the company as of January 9, 2026. He directly owns 121,367 shares of common stock. In addition, he holds several stock options to buy common shares, including 80,000 options at $15.23 expiring in 2029 and other grants through 2035 at exercise prices ranging from $7 to $35.20. Mark also holds restricted stock units, with 20,000 RSUs from a January 2024 grant and 53,000 RSUs from a January 2025 grant, each RSU representing the right to receive one share of common stock upon vesting.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Stock option granted March 27, 2019. Stock options vest as follows: (i) 25% of underlying shares of common stock on first anniversary of grant date and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of month following first anniversary of grant date. Stock option granted March 10, 2020. Stock option granted March 10, 2021. Stock option granted March 10, 2022. Stock option granted January 5, 2023. Stock option granted January 5, 2024. Stock option granted January 10, 2025. 60,000 restricted stock units ("RSUs") granted January 5, 2024; vest in three equal annual installments beginning January 5, 2025. As of January 9, 2026, 20,000 RSUs remain outstanding. Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of common stock. 53,000 restricted stock units ("RSUs") granted January 10, 2025; vest in three equal annual installments beginning January 10, 2026. As of January 9, 2026, 53,000 RSUs remain outstanding.
FAQ
Who is the insider reporting holdings in Zymeworks Inc. (ZYME)?
The insider is Hollywood Mark, who serves as EVP & Chief Operating Officer of Zymeworks Inc..
What stock options does Hollywood Mark hold in Zymeworks Inc.?
He holds multiple stock options (Right to Buy), including 80,000 options at $15.23 expiring on March 26, 2029, plus additional option grants through March 9, 2032, January 4, 2033, January 4, 2034, and January 9, 2035 at exercise prices from $7 to $35.20.
What restricted stock units (RSUs) are reported by Hollywood Mark for Zymeworks Inc.?
He reports 20,000 RSUs remaining from a 60,000 RSU grant on January 5, 2024, and 53,000 RSUs from a grant on January 10, 2025. As of January 9, 2026, all 53,000 RSUs from the 2025 grant remain outstanding.
How do Hollywood Mark’s RSUs in Zymeworks Inc. vest?
The 60,000 RSUs granted on January 5, 2024 vest in three equal annual installments beginning January 5, 2025. The 53,000 RSUs granted on January 10, 2025 vest in three equal annual installments beginning January 10, 2026.
What does each Zymeworks Inc. RSU reported by Hollywood Mark represent?
Each restricted stock unit (RSU) represents the contingent right to receive, upon vesting, one share of Zymeworks Inc. common stock.